Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
In Addendum BB, there are no relative payment weights displayed in the Final CY 2026 Payment Weight column for items and services with predetermined national payment amounts, such as separately payable drugs and biologicals
GLP1-GO is a privacy-first tracker for Mounjaro, Ozempic, Wegovy, Zepbound, Saxenda, and other GLP-1 weight-loss medications (including tirzepatide and semaglutide)
Primary effects: Appetite suppression through hypothalamic signaling, delayed gastric emptying, enhanced insulin secretion, reduced glucagon secretion
In phase 2 trials, cagrilintide alone produced dose-dependent reductions in body weight, with participants on the highest dose (4.5 mg weekly) losing roughly 10-15% of body weight over 26 weeks
US$ 28.62
US$ 25.92
US$ 25.18
US$ 24.85
US$ 27.46
US$ 27.22
US$ 29.25
US$ 24.52
